AdR1-TG/TALLYHO mice have improved lipid accumulation and insulin sensitivity

Area of Science:

• Metabolic disease research
• Endocrinology
• Molecular biology

Background:

• Adiponectin receptor 1 (AdR1) overexpression in macrophages modulates metabolic activities.
• Adiponectin enhances actions in distal tissues.
• Investigating AdR1's role in TALLYHO (TH) diabetic mice.

Purpose of the Study:

• To examine the effects of enhanced adiponectin actions on lipid accumulation and insulin sensitivity.
• To assess AdR1 overexpression in macrophages within a diabetic mouse model.

Main Methods:

• Crossed AdR1 macrophage-specific transgenic mice (AdR1-TG) with TALLYHO (TH) diabetic mice.
• Fed normal or high-fat diets for 28 weeks.
• Measured body weight, serum lipids, performed glucose/insulin tolerance tests, analyzed insulin signaling markers (IRS-1, AKT), insulin levels, Sirt1 gene expression, and Caspase 3 levels.

Main Results:

• AdR1-TG/TH mice exhibited lower body weight and decreased serum cholesterol, triglyceride, and free fatty acids compared to WT/TH controls.
• Improved glucose tolerance and insulin tolerance tests indicated enhanced systemic insulin sensitivity.
• Increased insulin secretion and Sirt1 gene expression were observed in AdR1-TG/TH mice, contrasting with pancreatic hypertrophy and high apoptosis in controls.

Conclusions:

• Enhanced adiponectin actions via macrophage AdR1 overexpression improve lipid accumulation and insulin sensitivity in TALLYHO diabetic mice.
• This suggests a beneficial interaction between macrophages and metabolic tissues.
• Adiponectin receptor 1 plays a key role in modulating systemic metabolism and improving diabetic conditions.